The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?

Author： Lee De-Hyung   Linker Ralf A  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.5, 2012-05, pp. : 451-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myelin Oligodendrocyte Glycoprotein and Multiple Sclerosis

By  

Medicinal Chemistry, Vol. 14, Iss. 2, 2018-02 ,pp. : 120-128

Bentham Science Publishers

Access to resources Recommend Favorite

Exploring the Role of Nerve Growth Factor in Multiple Sclerosis: Implications in Myelin Repair

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-01 ,pp. : 1242-1256

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 2, 2014-05 ,pp. : 134-143

Bentham Science Publishers

Access to resources Recommend Favorite

The autoimmune pathogenesis of multiple sclerosis

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 1, 2015-01 ,pp. : 5-11

Govi-Verlag

Access to resources Recommend Favorite

The autoimmune pathogenesis of multiple sclerosis

By  

PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. : 379-386

Govi-Verlag

Access to resources Recommend Favorite